A clinical study of a tumor-selective oncolytic adenovirus (Telomelysin) in combination with ionizing radiation for head and neck and thoracic malignant tumors
- Conditions
- Head and neck cancers, esophageal cancers, non-small cell lung cancers
- Registration Number
- JPRN-UMIN000010158
- Lead Sponsor
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Not provided
-Patient who has uncontrolled infectious disease and/or severe disease. -Patient who received chemotherapy, laser irradiation or stent placement within 3 weeks (or used nitrosourea or mitomycin C within 6 weeks). -Patient who receives non-local adrenocortical steroid therapy. -Patient who participated in clinical study of other unapproved drug within 4 weeks. -Patient who has or had (has less than 2 years after diagnosis of) other malignant tumors except for head and neck and thoracic malignant tumors. -Patient who cannot be kept or followed in this study due to mental, familial, social, geographical reasons. -Patient who has past history of autogenous or allogenic organ and tissue transplantations. -Patient who has positive result in serological test for HIV1, HIV2, HBV and HCV. -Patient who are considered inadequate by investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method